SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
PRER14A

Proxy soliciting materials. Revised preliminary material

Proxy Filings
View HTML
PRER14A

Proxy soliciting materials. Revised preliminary material

Proxy Filings
View HTML
REGDEX

REGDEX

Other
View HTML
S-1

Registration statement for face-amount certificate companies

Registration Statements
View HTML
S-1

Registration statement for face-amount certificate companies

Registration Statements
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML

Data provided by Kaleidoscope.

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe